Literature DB >> 31822191

Genetics of breast cancer: management strategies and risk-reducing surgery.

Rajesh Balasubramanian1, Rachel Rolph2, Catrin Morgan3, Hisham Hamed4.   

Abstract

The last two decades have witnessed major advances in genetic sequencing which have led to more accurate identification of women at risk of developing breast cancer and calculating the associated cancer risk. This review discusses the current genetic mutations conferring risk of developing breast cancer and the management pathway for these women with identifiable mutations as well as those with a strong family history for breast cancer. Management of these individuals is complex and should involve a multidisciplinary team with interest and expertise in breast cancer genetics. There are several treatment options ranging from surveillance to risk-reducing surgery. Risk reduction surgery has been popularised by celebrities who are carriers of breast cancer genes, and raised public awareness of breast cancer genetics and associated risk.

Entities:  

Mesh:

Year:  2019        PMID: 31822191     DOI: 10.12968/hmed.2019.80.12.720

Source DB:  PubMed          Journal:  Br J Hosp Med (Lond)        ISSN: 1750-8460            Impact factor:   0.825


  8 in total

Review 1.  Green Tea Epigallocatechin-3-Gallate Regulates Autophagy in Male and Female Reproductive Cancer.

Authors:  Sze Wan Hung; Yiran Li; Xiaoyan Chen; Kai On Chu; Yiwei Zhao; Yingyu Liu; Xi Guo; Gene Chi-Wai Man; Chi Chiu Wang
Journal:  Front Pharmacol       Date:  2022-07-04       Impact factor: 5.988

2.  Case Report: Development of Diffuse Large B Cell Lymphoma a Long Time After Hairy Cell Leukemia.

Authors:  Zsófia F Nagy; Kata Ferenczi; Ildikó Istenes; Hanna Eid; Csaba Bödör; Botond Timár; Judit Demeter
Journal:  Pathol Oncol Res       Date:  2022-04-29       Impact factor: 2.874

3.  LncRNA ST7-AS1 is a Potential Novel Biomarker and Correlated With Immune Infiltrates for Breast Cancer.

Authors:  Ziwen Zhang; Han Zhang; Dongbo Li; Xiaoping Zhou; Jinlu Wang; Qingyuan Zhang
Journal:  Front Mol Biosci       Date:  2021-04-12

4.  Synthesis, Molecular Docking Study, and Cytotoxic Activity against MCF Cells of New Thiazole-Thiophene Scaffolds.

Authors:  Sobhi M Gomha; Sayed M Riyadh; Bader Huwaimel; Mohie E M Zayed; Magda H Abdellattif
Journal:  Molecules       Date:  2022-07-20       Impact factor: 4.927

Review 5.  A narrative review of sociodemographic risk and disparities in screening, diagnosis, treatment, and outcomes of the most common extrathoracic malignancies in the United States.

Authors:  Sarah Singh; Praveen Sridhar
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

6.  Bioinformatics analysis on enrichment analysis of potential hub genes in breast cancer.

Authors:  Limin Wei; Yukun Wang; Dan Zhou; Xinyang Li; Ziming Wang; Ge Yao; Xinshuai Wang
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

7.  New 1,3,4-Thiadiazole Derivatives with Anticancer Activity.

Authors:  Sara Janowska; Dmytro Khylyuk; Anna Bielawska; Anna Szymanowska; Agnieszka Gornowicz; Krzysztof Bielawski; Jarosław Noworól; Sławomir Mandziuk; Monika Wujec
Journal:  Molecules       Date:  2022-03-10       Impact factor: 4.411

8.  Caspase-3-mediated GSDME induced Pyroptosis in breast cancer cells through the ROS/JNK signalling pathway.

Authors:  Ziwen Zhang; Han Zhang; Dongbo Li; Xiaoping Zhou; Qi Qin; Qingyuan Zhang
Journal:  J Cell Mol Med       Date:  2021-08-08       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.